Navigation Links
Ranbaxy Announces U.S. FDA Approval of CIP-Isotretinoin NDA
Date:5/29/2012

PRINCETON, N.J., May 29, 2012 /PRNewswire/ -- Ranbaxy Laboratories Inc. (RLI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), today announced today that the U.S. Food and Drug Administration (FDA) has approved Absorica™, a novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant nodular acne. Through a business agreement with the Canadian firm, Cipher Pharmaceuticals Inc., RLI is expected to launch Absorica™ in the U.S. in Q4 2012. As per the agreement, Ranbaxy will pay royalties on net sales to Cipher.

"We are thrilled to make Absorica available as a valuable option for the dermatologist and patients who need treatment for severe recalcitrant nodular acne. Absorica is a critical milestone in our commitment to serve the dermatology community and will be the flagship brand for Ranbaxy's specialized dermatology sales force," said Venkat Krishnan, Senior Vice President and Regional Director, Americas, Ranbaxy.

"Approval of Absorica represents our third FDA approval and most important milestone to date, reflecting the great work by our Scientific Affairs team at Cipher and our partner, Galephar Pharmaceutical Research," said Larry Andrews, President and CEO of Cipher. "We look forward to working closely with our partner, Ranbaxy Laboratories Inc., in preparation for the upcoming U.S. launch of the product through its dermatology sales force."

About Ranbaxy Laboratories Inc.
Ranbaxy Laboratories Inc. (RLI) is a U.S. based, wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL). RLI is focused on the promotion of branded prescription products in the U.S. RLI has been expanding and growing on the strength of Ranbaxy's R&D efforts, and continuing exploration of novel drug delivery systems (NDDS), licensing activities, mergers and acquisitions. RLI is expanding the visibility and presence of the Ranbaxy name by bringing value-added brand product
'/>"/>

SOURCE Ranbaxy Laboratories Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Department of Justice files consent decree of permanent injunction against Ranbaxy
2. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
3. Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344
4. Depomed Announces Filing Of Shelf Registration To Replace Existing Shelf
5. Mylan Announces Settlement Agreement in Litigation Relating to its Generic Xopenex®
6. Endo Announces Resolution of Patent Litigation with Watson Pharmaceuticals Related to Lidoderm®
7. Horizon Pharma Announces Issuance of U.S. Patent Covering RAYOS (delayed-release prednisone)
8. Watson Announces Lidoderm® Patent Challenge Settlement
9. Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
10. Acacia Pharma Announces Excellent Phase II Results for APD421 in Post-Operative Nausea & Vomiting (PONV)
11. Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovions Brovana® Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)...   Ventana Medical Systems, Inc.  (Ventana), a member ... into an agreement with Merck KGaA, Darmstadt, ... the United States and ... biopharmaceutical division on the development and commercialization of a ... proprietary diagnostic assays. In alignment with Merck KGaA,s strategic ...
(Date:1/15/2014)... Jan. 15, 2014 Sono-Tek Corporation (OTC BB: SOTK) today ... 30, 2013, compared to sales of $2,202,000 for the prior ... this quarter has also shown growth over the preceding quarter,s ... of this fiscal year. Markets that experienced sales increases over ...
(Date:1/15/2014)... 15, 2014 AARP Foundation today announced it has established ... from the severe cold weather that has gripped much of ... those in need; so to support these emergency relief efforts ... $250,000, which could mean up to $500,000 in aid. The ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3
... Calif., Oct. 1 NeurogesX, Inc. (Nasdaq: NGSX ... novel pain management therapies, announced today that Anthony DiTonno, ... at the Fourth Annual JMP Securities Healthcare Focus Conference, ... New York City. , Mr. DiTonno and Stephen Ghiglieri, ...
... Oct. 1 The Prix Galien USA committee celebrated ... for the development and discovery of drugs and technologies ... and Veridex were honored with the 2009 Prix Galien ... and development, for treatments that could change the course ...
Cached Medicine Technology:NeurogesX to Present at JMP Securities Healthcare Focus Conference 2NeurogesX to Present at JMP Securities Healthcare Focus Conference 3Prix Galien USA Honors Innovation in Science and Biotech Industries 2
(Date:7/11/2014)... July 11, 2014 Recently, Fadhits.com, the distinguished ... of kids prom dresses . To bring more benefits ... has also launched a special offer for these brand new ... 2014. , The company’s sales manager says gladly, “We are ... special offer is to acknowledge all new and old customers ...
(Date:7/11/2014)... Women would benefit from being prescribed exercise as ... moderate to high intensity activity is essential to ... , Professor Debra Anderson, from QUT,s Institute of ... to conventional treatments for physical and mental health, ... for older women. , Professor Anderson and QUT,s ...
(Date:7/11/2014)... New research conducted at Aarhus University has revealed that ... livestock are only half as likely as their urban ... ulcerative colitis and Crohn,s disease. The study findings have ... Epidemiology . , "It is extremely exciting that we ... also more classic inflammatory diseases appear to depend on ...
(Date:7/11/2014)... Emily Johnson, owner of the Portland Fit Body Boot Camp, ... has held two charity workout events and is about to ... 7:15 - 8:30 at Col Summers City Park, SE 20th and ... raised $510 for Medical Teams International. Their second workout event resulted ... On July 26th, Johnson and Portland Fit Body Boot Camp ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Recently, iFitDress.com, ... special occasion outfits, has released its new collection of ... that, the company has announced that all these beautiful ... off. The deadline of the special offer is July ... its major officials pay close attention to customer satisfaction. ...
Breaking Medicine News(10 mins):Health News:Promotion for Kids Prom Dresses Now Provided at Fadhits.com 2Health News:Exercise is the best medicine: QUT study 2Health News:Growing up on a livestock farm halves the risk of inflammatory bowel diseases 2Health News:Portland Fit Body Boot Camp Invites Public to Fitness Boot Camp Session Benefiting Children’s Cancer Association 2Health News:Portland Fit Body Boot Camp Invites Public to Fitness Boot Camp Session Benefiting Children’s Cancer Association 3Health News:Worldwide Chic Ladies Can Buy Cheap Evening Dresses at iFitDress.com 2
... -- The prestigious BBVA Foundation Frontiers of Knowledge Award ... J. Lefkowitz, M.D., James B. Duke Professor of Medicine ... investigator at Duke University Medical Center. This is only ... Dr. Lefkowitz,s research has affected millions of cardiac and ...
... U.S. Department of Energy,s National Nuclear Security Administration (NNSA) ... of radioisotopes, which are used to help millions of ... cancer, thyroid and heart disease. Earlier this week, ... develop a U.S. supply of Molybdenum-99 (Mo-99). Babcock & ...
... a new generation of products aimed at making cleaning ... in the current issue of Chemical & Engineering News ... Editor Michael McCoy points out in the cover story ... occurring despite a rocky economy in 2009, which led ...
... scent of urine could catch disease quickly , WEDNESDAY, Jan. 27 ... that can detect lung cancer simply on the basis of a ... is so far based solely on work with mice, but follow-up ... in the early diagnosis of lung cancer in humans. , "But ...
... ... regenerates dormant hair follicles to produce new growth is not being recommended by the researchers ... effective hair loss treatment options are already available. , ... (PRWeb UK) January 28, 2010 -- Researchers and hair restoration surgeons ...
... , WASHINGTON , Jan. 27 ... (SCAI) launched "WINHeart -- Score a WIN for Women," ... the diagnosis, treatment and survival of women with cardiovascular ... of interventional cardiologists within SCAI, today released a new ...
Cached Medicine News:Health News:Renowned Duke researcher wins Frontiers of Knowledge Award 2Health News:SNM applauds US Department of Energy's move to develop domestic radioisotope supply 2Health News:New Test Might 'Smell' Early Stage Lung Cancer 2Health News:New Test Might 'Smell' Early Stage Lung Cancer 3Health News:Hair Cloning Not Yet Recommended by Researchers Who Developed the Technique 2Health News:New Report and Survey Findings Highlight Why More Women Die From Heart Disease Than Men 2Health News:New Report and Survey Findings Highlight Why More Women Die From Heart Disease Than Men 3Health News:New Report and Survey Findings Highlight Why More Women Die From Heart Disease Than Men 4Health News:New Report and Survey Findings Highlight Why More Women Die From Heart Disease Than Men 5
... Medical Professional Diagnostics is a leading provider ... and DFA test menu that includes kits ... as well as miscellaneous conjugates and components. ... a wide assortment of substrates and kit ...
... Medical Professional Diagnostics is a leading provider ... and DFA test menu that includes kits ... as well as miscellaneous conjugates and components. ... a wide assortment of substrates and kit ...
... Medical Professional Diagnostics is a leading provider ... and DFA test menu that includes kits ... as well as miscellaneous conjugates and components. ... a wide assortment of substrates and kit ...
... Inverness Medical Professional Diagnostics is a leading ... IFA and DFA test menu that includes ... STDs as well as miscellaneous conjugates and ... you a wide assortment of substrates and ...
Medicine Products: